We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

XenoGesis and Juniper Pharma Services Strengthen Alliance

Campanies extend strategic alliance in early drug development services.
News

Model Predicts How E. coli Bacteria Adapt Under Stress

Scientists have developed a genome-scale model that can accurately predict how E. coli bacteria respond to temperature changes and genetic mutations, providing systems-level understanding of how cells adapt under environmental stress.
News

DataArt Joins Biotechnology Association BIO Deutschland

Global technology consultancy DataArt announced today that it has joined BIO Deutschland, Germany's biotechnology industry association.
News

Nanopore Technology Applied to Proteome Sequencing

Scientists have designed a nanopore to identify the fingerprints of proteins and peptides that can even detect polypeptides differing by one amino acid.
News

Compliant-Ready LIMS Launched by LabVantage

LabVantage launches LIMS software that is the first GxP-compliant solution for data integrity and auditing, to help drug manufacturers conform to the FDA draft guidance on “Data Integrity and Compliance with CGMP.”
News

Multi-tissue, Multi-individual Data Used to Identify Mechanisms of Gene Regulation

Developing a mechanistic model for how healthy bodies function and how certain diseases merge may now be possible.
News

BC Platforms Announces Collaborations in Multiple Sclerosis Research

Company's technology and research platforms used to better understand genetic basis of MS.
News

WGS Identifies New Genetic Signature for Autism

An analysis of the complete genomes of 2,064 people reveals that multiple genetic variations could contribute to autism.
News

Qlucore Celebrates 10 Years

In October 2017 Qlucore celebrates a decade of helping researchers to visualize and analyze their data with Qlucore Omics Explorer software.
News

TOX protein identified in T-cell acute lymphoblastic leukemia development.

A newly identified cancer-causing pathway behind most cases of an aggressive type of leukemia could lead to new targeted treatment approaches.
Advertisement